Patent intelligence · US
US 7374754
Use of placental alkaline phosphatase to promote skin cell proliferation
Use of placental alkaline phosphatase to promote skin cell proliferation
Patent details — US 7374754
- Jurisdiction
- US
- Status
- granted
- Grant date
- May 20, 2008
- Expiration
- May 15, 2028
- Applicant
- Essential Skincare, LLC
- Claims
- 29
- CPC classes
- A61K, A61K38/465, A61K8/66
Quick answer
US 7374754 (Use of placental alkaline phosphatase to promote skin cell proliferation) is held by Essential Skincare, LLC. Status: granted. Granted May 20, 2008. Expires May 15, 2028 (2 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- Essential Skincare, LLC
- Grant date
- Expiration
- Claims
- 29
- CPC classes
- A61K, A61K38/465, A61K8/66
More from Essential Skincare, LLC
Related pharmaceutical patents in our USPTO index.
-
US 12419895
Methods for treating subjects with Prader-Willi syndrome
granted -
US 12350258
Compositions and methods for treatment of skin-related diseases and promoting dermatological health
granted -
US 12343348
Methods for treating subjects with Prader-Willi syndrome or Smith-Magenis syndrome
granted -
US 12343381
Dosage regimen for pegylated interferon
granted -
US 12178823
Methods for treating subjects with Prader-Willi syndrome or Smith-Magenis syndrome
granted -
US 12109216
Methods for treating subjects with Prader-Willi syndrome or Smith-Magenis syndrome
granted -
US 12005081
Chimeric receptors and methods of use thereof
granted -
US 11884656
Pyrrole derivatives as PLK1 inhibitors
granted
Frequently asked questions
What is US patent 7374754?
US 7374754 (Use of placental alkaline phosphatase to promote skin cell proliferation) is held by Essential Skincare, LLC. Status: granted. Granted May 20, 2008. Expires May 15, 2028 (2 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 7374754?
Essential Skincare, LLC is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 95 pharmaceutical patents for this assignee.
When does US 7374754 expire?
Our index shows an expiration date of May 15, 2028 (2 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.